Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PR104 and docetaxel in advanced NSCLC
NCT00862134Phase 2Terminated
- Sponsor
- Proacta Inc.
- Start
- Mar 2009
- Primary completion
- Jan 2010
- Countries
- 3
01
Overview
A Phase 2 trial of PR-104 in non-small cell lung cancer (NSCLC), sponsored by Proacta Inc.. Started Mar 2009; status: terminated.
02
Drugs
PR-104
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00862134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862134.